BioWorld MedTech

Jan. 23, 2013

Selventa focuses on developing personalized care diagnostics

Selventa (Cambridge, Massachusetts) reported that it plans to introduce a new class of diagnostic test that would promote personalized healthcare technologies. Read More

Welch Allyn gains FDA clearance for iExaminer

Report from Europe: EU urged to act quickly on key med-tech regulations

Washington roundup: Covering OCT for verteporfin helps docs, not device makers

Financings roundup: MRI Interventions enters into securities purchase agreement

Agreements/contracts: Xifin uses PAML account management platforms

Deals roundup: Aetna in plan to sell Missouri Care to WHP

HIT roundup: New Mexico HIE to use Orion platform statewide

People in the News

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 9, 2025.

Many med-tech company supply chains protected from tariffs

BioWorld MedTech

In the wake of the pandemic, many leading med-tech companies took steps to on-shore and near-shore manufacturing, a move that could protect significant numbers of...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Many US tariffs paused, pharma warned, EU put on notice

BioWorld

The on-again, off-again U.S. tariffs are off again, at least for now, for more than 75 countries that have reached out to the Trump administration to negotiate...